Effect of Cannabis Use Disorder on Total Shoulder
Arthroplasty Outcomes
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Table 1. Demographic comparison of patients undergoing TSA
for primary osteoarthritis with and without a comorbid diagnosis
of Cannabis Use Disorder (CUD)

Purpose

Table 2. Univariate analysis of long term (2-year) and 90-Day
outcomes

Cannabis use has been legalized for recreational use in eighteen states since 2012,
1
with legalization expected to occur in additional states in the future . Existing
studies have found Cannabis Use Disorder (CUD) to be associated with increased
2
incidence of perioperative complications in lower extremity arthroplasty .
However, studies examining CUD following total shoulder arthroplasty (TSA) are
limited. The aim of this study was to evaluate the effect of comorbid CUD on
2-year revision and 90-day postoperative outcomes in primary TSA for
osteoarthritis.

Materials and Methods
A retrospective study was designed using the PearlDiver Patient Records
Database. Data was queried from the Mariner dataset, which includes over 121
million patient records from 2010-2020. CPT, ICD-9, and ICD-10 codes were
used to identify patients undergoing TSA for the indication of osteoarthritis and
were divided into a CUD and control group. The primary outcomes of interest
were 2-year all-cause revision, 90-day hospital readmission, and 90-day
emergency department visit. Surgical perioperative complications investigated
included PJI, periprosthetic fracture, mechanical loosening, articular bearing
surface wear, broken prosthesis, and prosthetic dislocation. Univariate analysis
and multivariable logistic regression were used to analyze the data.

Results

Table 3. Multivariable logistic regression analysis* of long term
(2-year) and 90-Day outcomes

A total of N=114,947 patients undergoing TSA were identified. The CUD cohort
contained N=510 patients and the control cohort contained N=114,437 patients.
When controlled for comorbidities, there were no statistically significant
differences in 2-year revision outcomes. Multivariable results also showed no
association with 90-day medical or surgical complications, with the exception
of 90-day presentation to an Emergency Department.

Figure 1. Univariate analysis of long term (2-year) and 90-Day
outcomes

2

Discussion
Our results showed that CUD is not an independent risk factor for 2-year
revision surgery, nor is it independently associated with adverse 90-day
medical or surgical complications. The results of this research expands the
literature on TSA and comorbid substance use. Further, our findings can assist
orthopedic surgeons in counseling patients regarding CUD as a risk factor for
complications of TSA.
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